ISCATECH   Bedoukian   RussellIPM   Piezoelectric Micro-Sprayer

Animal Taxa
Plant Taxa
Floral Compounds
Semiochemical Detail
Semiochemicals & Taxa
Invasive spp.



Email to a Friend
Kindly Donate for The Pherobase

« Previous AbstractPatient Protection and Affordable Care Act: promise and peril for primary care    Next AbstractDemographics and trends in wheeled mobility equipment use and accessibility in the community »


Title:Estimating hourly anaesthetic and surgical reimbursement from private medical insurers' benefit maxima: implications for pricing services and for incentives
Author(s):Stubbs, D. Ward, M. E. Pandit, J. J.
Address:Nuffield Department of Anaesthetics, John Radcliffe Hospital, Oxford, UK.
Year:2010 Apr
Journal Title:Anaesthesia
Page Number:396-408
ISSN/ISBN:1365-2044 (Electronic). 0003-2409 (Linking)
Abstract:While some speculation surrounds annual private practice incomes of anaesthetists, little is known of the hours of work needed to generate any presumed income (the hourly rate). The benefit maxima of five private medical insurers are published in fee schedules and data on the duration of common operations are now also known. In this study we combined these to generate estimates for hourly rates of reimbursement across 78 common operations in eight surgical subspecialties, for anaesthetists and surgeons. We expected to find significant differences between insurers as a result of market competition, and we expected differences between anaesthetists and surgeons. The median (IQR [range]) rate of reimbursement for anaesthetists was pound167 (132-211 [68-570]).h(-1) with significant variation across subspecialties (p < 0.001); for example, cardiac surgery was best reimbursed at pound283 (257-308 [229-398]).h(-1) and orthopaedics the least at pound146 (133-159 [81-246]).h(-1). Contrary to expectations, the rates of payment to anaesthetists by insurers were similar (p > 0.17). Patterns of reimbursement for surgeons were similar to those for anaesthetists, except that surgeons were reimbursed at about twice the rate. We conclude there is a confluence of insurer reimbursement levels and we discuss potential implications of this finding. Our results also have implications for how incentives between the NHS and private practice, or within a private practice group, might be optimally managed.

Back to top
Citation: El-Sayed AM 2021. The Pherobase: Database of Pheromones and Semiochemicals. <>.
© 2003-2021 The Pherobase - Extensive Database of Pheromones and Semiochemicals. Ashraf M. El-Sayed.
Page created on 15-01-2021